Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
41.10
-2.64 (-6.04%)
At close: Feb 27, 2026, 4:00 PM EST
41.05
-0.05 (-0.12%)
After-hours: Feb 27, 2026, 7:04 PM EST
Crinetics Pharmaceuticals Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$75.78
Upside
+84.38%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $67 | Hold → Strong Buy | Upgrades | $67 | +63.02% | Jan 12, 2026 |
| Citizens | Citizens | Buy Maintains $108 → $105 | Buy | Maintains | $108 → $105 | +155.47% | Jan 8, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $77 → $80 | Buy | Maintains | $77 → $80 | +94.65% | Jan 6, 2026 |
| Citizens | Citizens | Buy Maintains $143 → $108 | Buy | Maintains | $143 → $108 | +162.77% | Nov 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $73 → $87 | Buy | Maintains | $73 → $87 | +111.68% | Sep 30, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $65 → $77 | Buy | Maintains | $65 → $77 | +87.35% | Sep 29, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $80 → $88 | Buy | Maintains | $80 → $88 | +114.11% | Sep 29, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $35 → $40 | Hold | Maintains | $35 → $40 | -2.68% | Sep 26, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $86 → $143 | Buy | Maintains | $86 → $143 | +247.93% | Sep 26, 2025 |
| Baird | Baird | Buy Maintains $58 → $62 | Buy | Maintains | $58 → $62 | +50.85% | Sep 26, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $53 → $52 | Buy | Maintains | $53 → $52 | +26.52% | Sep 24, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $90 → $86 | Buy | Maintains | $90 → $86 | +109.25% | Aug 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $81 | Strong Buy | Reiterates | $81 | +97.08% | Jun 27, 2025 |
| Stifel | Stifel | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +45.99% | Mar 25, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Maintains $92 → $91 | Buy | Maintains | $92 → $91 | +121.41% | Feb 28, 2025 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 4, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.